Cartesian Therapeutics announces FDA agreement for new trial
28th January 2025 Uncategorised 0
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25

More: Cartesian Therapeutics announces FDA agreement for new trial
Source: News
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25

More: Cartesian Therapeutics announces FDA agreement for new trial
Source: News
© 1994 - 2026 B.M. Pharmaceuticals